{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:37:01Z","timestamp":1791927421556,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Anhui Province University Collaborative Innovation Project","award":["GXXT-2021-087"],"award-info":[{"award-number":["GXXT-2021-087"]}]},{"name":"Anhui Provincial Quality Engineering for Colleges and Universities","award":["2019zyrc063"],"award-info":[{"award-number":["2019zyrc063"]}]},{"name":"Quality Engineering Project of Wannan Medical College","award":["2019ylzy01"],"award-info":[{"award-number":["2019ylzy01"]}]},{"name":"Key Projects of Anhui Provincial Department of Education","award":["KJ2021A0836"],"award-info":[{"award-number":["KJ2021A0836"]}]},{"name":"Key scientific research project of Wannan Medical College","award":["grant number WK2020Z07"],"award-info":[{"award-number":["grant number WK2020Z07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10552-024-01865-5","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T18:01:18Z","timestamp":1716141678000},"page":"1271-1282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017\u20132018"],"prefix":"10.1007","volume":"35","author":[{"given":"Yuxiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanjiamei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue\u2019e","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,19]]},"reference":[{"key":"1865_CR1","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41370-021-00288-7","volume":"31","author":"AS Young","year":"2021","unstructured":"Young AS, Sparer-Fine EH, Pickard HM, Sunderland EM, Peaslee GF, Allen JG (2021) Per- and polyfluoroalkyl substances (PFAS) and total fluorine in fire station dust. J Expo Sci Environ Epidemiol 31:930\u2013942. https:\/\/doi.org\/10.1038\/s41370-021-00288-7","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"1865_CR2","doi-asserted-by":"publisher","first-page":"127001","DOI":"10.1289\/ehp10103","volume":"130","author":"WA Chiu","year":"2022","unstructured":"Chiu WA, Lynch MT, Lay CR et al (2022) Bayesian estimation of human population toxicokinetics of PFOA, PFOS, PFHxS, and PFNA from studies of contaminated drinking water. Environ Health Perspect 130:127001. https:\/\/doi.org\/10.1289\/ehp10103","journal-title":"Environ Health Perspect"},{"key":"1865_CR3","doi-asserted-by":"publisher","first-page":"46001","DOI":"10.1289\/ehp10092","volume":"130","author":"E Costello","year":"2022","unstructured":"Costello E, Rock S, Stratakis N et al (2022) Exposure to per-and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis. Environ Health Perspect 130:46001. https:\/\/doi.org\/10.1289\/ehp10092","journal-title":"Environ Health Perspect"},{"key":"1865_CR4","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1021\/es0493446","volume":"38","author":"K Kannan","year":"2004","unstructured":"Kannan K, Corsolini S, Falandysz J et al (2004) Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 38:4489\u20134495. https:\/\/doi.org\/10.1021\/es0493446","journal-title":"Environ Sci Technol"},{"key":"1865_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073730","author":"JM Graber","year":"2021","unstructured":"Graber JM, Black TM, Shah NN et al (2021) Prevalence and predictors of per-and polyfluoroalkyl substances (PFAS) serum levels among members of a suburban US volunteer fire department. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18073730","journal-title":"Int J Environ Res Public Health"},{"key":"1865_CR6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1039\/d1em00228g","volume":"23","author":"Y Cao","year":"2021","unstructured":"Cao Y, Ng C (2021) Absorption, distribution, and toxicity of per-and polyfluoroalkyl substances (PFAS) in the brain: a review. Environ Sci Process Impacts 23:1623\u20131640. https:\/\/doi.org\/10.1039\/d1em00228g","journal-title":"Environ Sci Process Impacts"},{"key":"1865_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/etc.4890","volume":"40","author":"SE Fenton","year":"2021","unstructured":"Fenton SE, Ducatman A, Boobis A et al (2021) Per-and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem 40:606\u2013630. https:\/\/doi.org\/10.1002\/etc.4890","journal-title":"Environ Toxicol Chem"},{"key":"1865_CR8","doi-asserted-by":"publisher","first-page":"113431","DOI":"10.1016\/j.envres.2022.113431","volume":"212","author":"LEL Jane","year":"2022","unstructured":"Jane LEL, Yamada M, Ford J, Owens G, Prow T, Juhasz A (2022) Health-related toxicity of emerging per-and polyfluoroalkyl substances: comparison to legacy PFOS and PFOA. Environ Res 212:113431. https:\/\/doi.org\/10.1016\/j.envres.2022.113431","journal-title":"Environ Res"},{"key":"1865_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/biolre\/ioab223","volume":"106","author":"Z Aghaei","year":"2022","unstructured":"Aghaei Z, Steeves KL, Jobst KJ, Cahill LS (2022) The impact of perfluoroalkyl substances on pregnancy, birth outcomes, and offspring development: a review of data from mouse models\u2020. Biol Reprod 106:397\u2013407. https:\/\/doi.org\/10.1093\/biolre\/ioab223","journal-title":"Biol Reprod"},{"key":"1865_CR10","doi-asserted-by":"publisher","first-page":"119269","DOI":"10.1016\/j.envpol.2022.119269","volume":"305","author":"T Ding","year":"2022","unstructured":"Ding T, Yan W, Zhou T et al (2022) Endocrine disrupting chemicals impact on ovarian aging: evidence from epidemiological and experimental evidence. Environ Pollut 305:119269. https:\/\/doi.org\/10.1016\/j.envpol.2022.119269","journal-title":"Environ Pollut"},{"key":"1865_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"1865_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R (2021) Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 18:223\u2013238. https:\/\/doi.org\/10.1038\/s41575-020-00381-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1865_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","volume":"75","author":"Y Nan","year":"2021","unstructured":"Nan Y, An J, Bao J et al (2021) The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. J Hepatol 75:454\u2013461. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.003","journal-title":"J Hepatol"},{"key":"1865_CR14","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1111\/liv.14548","volume":"40","author":"S Lin","year":"2020","unstructured":"Lin S, Huang J, Wang M et al (2020) Comparison of MAFLD and NAFLD diagnostic criteria in real world. Liver international: off J Int Assoc Study Liver 40:2082\u20132089. https:\/\/doi.org\/10.1111\/liv.14548","journal-title":"Liver international: off J Int Assoc Study Liver"},{"key":"1865_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2020.12.025","volume":"74","author":"M Eslam","year":"2021","unstructured":"Eslam M, Ratziu V, George J (2021) Yet more evidence that MAFLD is more than a name change. J Hepatol 74:977\u2013979. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.025","journal-title":"J Hepatol"},{"key":"1865_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"1865_CR17","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton C, Upendran Y, Zheng MH, George J (2023) MAFLD: how is it different from NAFLD? Clin Mol Hepatol 29:S17-s31. https:\/\/doi.org\/10.3350\/cmh.2022.0367","journal-title":"Clin Mol Hepatol"},{"key":"1865_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/med.21515","volume":"39","author":"J Cai","year":"2019","unstructured":"Cai J, Zhang XJ, Li H (2019) Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Med Res Rev 39:328\u2013348. https:\/\/doi.org\/10.1002\/med.21515","journal-title":"Med Res Rev"},{"key":"1865_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100231","volume":"3","author":"S Myers","year":"2021","unstructured":"Myers S, Neyroud-Caspar I, Spahr L et al (2021) NAFLD and MAFLD as emerging causes of HCC: A populational study. JHEP Rep: Innov Hepatol 3:100231. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100231","journal-title":"JHEP Rep: Innov Hepatol"},{"key":"1865_CR20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1080\/00365521.2022.2041085","volume":"57","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Li H (2022) Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease. Scand J Gastroenterol 57:872\u2013877. https:\/\/doi.org\/10.1080\/00365521.2022.2041085","journal-title":"Scand J Gastroenterol"},{"key":"1865_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhep.2021.09.039","volume":"76","author":"P Sen","year":"2022","unstructured":"Sen P, Qadri S, Luukkonen PK et al (2022) Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease. J Hepatol 76:283\u2013293. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.039","journal-title":"J Hepatol"},{"key":"1865_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107179","volume":"163","author":"JJ Liu","year":"2022","unstructured":"Liu JJ, Cui XX, Tan YW et al (2022) Per- and perfluoroalkyl substances alternatives, mixtures and liver function in adults: a community-based population study in China. Environ Int 163:107179. https:\/\/doi.org\/10.1016\/j.envint.2022.107179","journal-title":"Environ Int"},{"key":"1865_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/jom.0000000000001532","volume":"61","author":"RB Jain","year":"2019","unstructured":"Jain RB, Ducatman A (2019) Selective associations of recent low concentrations of perfluoroalkyl substances with liver function biomarkers: NHANES 2011 to 2014 data on US adults aged \u226520 years. J Occup Environ Med 61:293\u2013302. https:\/\/doi.org\/10.1097\/jom.0000000000001532","journal-title":"J Occup Environ Med"},{"key":"1865_CR24","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1007\/s11356-017-0872-7","volume":"25","author":"X Wu","year":"2018","unstructured":"Wu X, Xie G, Xu X, Wu W, Yang B (2018) Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice. Environ Sci Pollut Res Int 25:4787\u20134793. https:\/\/doi.org\/10.1007\/s11356-017-0872-7","journal-title":"Environ Sci Pollut Res Int"},{"key":"1865_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100550","volume":"4","author":"JA Goodrich","year":"2022","unstructured":"Goodrich JA, Walker D, Lin X et al (2022) Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep 4:100550. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100550","journal-title":"JHEP Rep"},{"key":"1865_CR26","doi-asserted-by":"publisher","first-page":"105220","DOI":"10.1016\/j.envint.2019.105220","volume":"134","author":"R Jin","year":"2020","unstructured":"Jin R, McConnell R, Catherine C et al (2020) Perfluoroalkyl substances and severity of nonalcoholic fatty liver in children: an untargeted metabolomics approach. Environ Int 134:105220. https:\/\/doi.org\/10.1016\/j.envint.2019.105220","journal-title":"Environ Int"},{"key":"1865_CR27","doi-asserted-by":"publisher","first-page":"108138","DOI":"10.1016\/j.envint.2023.108138","volume":"178","author":"W Yang","year":"2023","unstructured":"Yang W, Ling X, He S et al (2023) PPAR\u03b1\/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per-and polyfluoroalkyl substances: an integrated approach. Environ Int 178:108138. https:\/\/doi.org\/10.1016\/j.envint.2023.108138","journal-title":"Environ Int"},{"key":"1865_CR28","doi-asserted-by":"publisher","first-page":"117007","DOI":"10.1016\/j.envpol.2021.117007","volume":"283","author":"SH Lee","year":"2021","unstructured":"Lee SH, Tseng WC, Du ZY et al (2021) Lipid responses to environmental perfluoroalkyl substance exposure in a Taiwanese Child cohort. Environ Pollut 283:117007","journal-title":"Environ Pollut"},{"key":"1865_CR29","doi-asserted-by":"publisher","first-page":"115991","DOI":"10.1016\/j.taap.2022.115991","volume":"442","author":"E Marques","year":"2022","unstructured":"Marques E, Pfohl M, Wei W et al (2022) Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. Toxicol Appl Pharmacol 442:115991. https:\/\/doi.org\/10.1016\/j.taap.2022.115991","journal-title":"Toxicol Appl Pharmacol"},{"key":"1865_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1091581818790934","volume":"37","author":"I Huck","year":"2018","unstructured":"Huck I, Beggs K, Apte U (2018) Paradoxical protective effect of perfluorooctanesulfonic acid against high-fat diet-induced hepatic steatosis in mice. Int J Toxicol 37:383\u2013392. https:\/\/doi.org\/10.1177\/1091581818790934","journal-title":"Int J Toxicol"},{"key":"1865_CR31","doi-asserted-by":"publisher","first-page":"106408","DOI":"10.1016\/j.envint.2021.106408","volume":"149","author":"Y Wang","year":"2021","unstructured":"Wang Y, Aimuzi R, Nian M, Zhang Y, Luo K, Zhang J (2021) Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013\u20132016. Environ Int 149:106408. https:\/\/doi.org\/10.1016\/j.envint.2021.106408","journal-title":"Environ Int"},{"key":"1865_CR32","doi-asserted-by":"publisher","first-page":"67007","DOI":"10.1289\/ehp10393","volume":"130","author":"X Wen","year":"2022","unstructured":"Wen X, Wang M, Xu X, Li T (2022) Exposure to per- and polyfluoroalkyl substances and mortality in US adults: a population-based cohort study. Environ Health Perspect 130:67007. https:\/\/doi.org\/10.1289\/ehp10393","journal-title":"Environ Health Perspect"},{"key":"1865_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML et al (2019) Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol: Off Clin Practice J Am Gastroenterol Assoc 17:156\u201363.e2. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.043","journal-title":"Clin Gastroenterol Hepatol: Off Clin Practice J Am Gastroenterol Assoc"},{"key":"1865_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021787","volume":"8","author":"W Jiang","year":"2018","unstructured":"Jiang W, Huang S, Teng H et al (2018) Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis. BMJ Open 8:e021787. https:\/\/doi.org\/10.1136\/bmjopen-2018-021787","journal-title":"BMJ Open"},{"key":"1865_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2214\/ajr.15.14553","volume":"205","author":"A Tang","year":"2015","unstructured":"Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound elastography and MR elastography for assessing liver fibrosis: part 2, diagnostic performance, confounders, and future directions. AJR Am J Roentgenol 205:33\u201340. https:\/\/doi.org\/10.2214\/ajr.15.14553","journal-title":"AJR Am J Roentgenol"},{"key":"1865_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2214\/ajr.15.14552","volume":"205","author":"A Tang","year":"2015","unstructured":"Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound elastography and MR elastography for assessing liver fibrosis: part 1, principles and techniques. AJR Am J Roentgenol 205:22\u201332. https:\/\/doi.org\/10.2214\/ajr.15.14552","journal-title":"AJR Am J Roentgenol"},{"key":"1865_CR37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.cgh.2020.08.017","volume":"19","author":"D Kim","year":"2021","unstructured":"Kim D, Cholankeril G, Loomba R, Ahmed A (2021) Prevalence of fatty liver disease and fibrosis detected by transient elastography in adults in the United States, 2017\u20132018. Clin Gastroenterol Hepatol: Off Clin Practice J Am Gastroenterol Assoc 19:1499\u2013501.e2. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.017","journal-title":"Clin Gastroenterol Hepatol: Off Clin Practice J Am Gastroenterol Assoc"},{"key":"1865_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/oxfordjournals.epirev.a017925","volume":"18","author":"NL Benowitz","year":"1996","unstructured":"Benowitz NL (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188\u2013204. https:\/\/doi.org\/10.1093\/oxfordjournals.epirev.a017925","journal-title":"Epidemiol Rev"},{"key":"1865_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.scitotenv.2017.04.058","volume":"596\u2013597","author":"LS Mamsen","year":"2017","unstructured":"Mamsen LS, J\u00f6nsson BAG, Lindh CH et al (2017) Concentration of perfluorinated compounds and cotinine in human foetal organs, placenta, and maternal plasma. Sci Total Environ 596\u2013597:97\u2013105. https:\/\/doi.org\/10.1016\/j.scitotenv.2017.04.058","journal-title":"Sci Total Environ"},{"key":"1865_CR40","doi-asserted-by":"publisher","first-page":"44292","DOI":"10.1007\/s11356-023-25258-4","volume":"30","author":"E Limei","year":"2023","unstructured":"Limei E, Zhang S, Jiang X (2023) Association between perfluoroalkyl substances exposure and the prevalence of nonalcoholic fatty liver disease in the different sexes: a study from the National Health and Nutrition Examination Survey 2005\u20132018. Environ Sci Pollut Res Int 30:44292\u201344303. https:\/\/doi.org\/10.1007\/s11356-023-25258-4","journal-title":"Environ Sci Pollut Res Int"},{"key":"1865_CR41","doi-asserted-by":"publisher","first-page":"64342","DOI":"10.1007\/s11356-023-26941-2","volume":"30","author":"Z Wu","year":"2023","unstructured":"Wu Z, Ouyang T, Liu H, Cao L, Chen W (2023) Perfluoroalkyl substance (PFAS) exposure and risk of nonalcoholic fatty liver disease in the elderly: results from NHANES 2003\u20132014. Environ Sci Pollut Res Int 30:64342\u201364351. https:\/\/doi.org\/10.1007\/s11356-023-26941-2","journal-title":"Environ Sci Pollut Res Int"},{"key":"1865_CR42","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.envint.2010.08.001","volume":"37","author":"E Goosey","year":"2011","unstructured":"Goosey E, Harrad S (2011) Perfluoroalkyl compounds in dust from Asian, Australian, European, and North American homes and UK cars, classrooms, and offices. Environ Int 37:86\u201392. https:\/\/doi.org\/10.1016\/j.envint.2010.08.001","journal-title":"Environ Int"},{"key":"1865_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.toxlet.2020.04.012","volume":"329","author":"Y Wen","year":"2020","unstructured":"Wen Y, Chen J, Li J, Arif W, Kalsotra A, Irudayaraj J (2020) Effect of PFOA on DNA methylation and alternative splicing in mouse liver. Toxicol Lett 329:38\u201346. https:\/\/doi.org\/10.1016\/j.toxlet.2020.04.012","journal-title":"Toxicol Lett"},{"key":"1865_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.toxrep.2019.12.010","volume":"7","author":"F Rashid","year":"2020","unstructured":"Rashid F, Ramakrishnan A, Fields C, Irudayaraj J (2020) Acute PFOA exposure promotes epigenomic alterations in mouse kidney tissues. Toxicol Rep 7:125\u2013132. https:\/\/doi.org\/10.1016\/j.toxrep.2019.12.010","journal-title":"Toxicol Rep"},{"key":"1865_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.envres.2019.05.008","volume":"175","author":"M Xu","year":"2019","unstructured":"Xu M, Wan J, Niu Q, Liu R (2019) PFOA and PFOS interact with superoxide dismutase and induce cytotoxicity in mouse primary hepatocytes: a combined cellular and molecular methods. Environ Res 175:63\u201370. https:\/\/doi.org\/10.1016\/j.envres.2019.05.008","journal-title":"Environ Res"},{"key":"1865_CR46","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/ajg.2009.707","volume":"105","author":"CY Lin","year":"2010","unstructured":"Lin CY, Lin LY, Chiang CK et al (2010) Investigation of the associations between low-dose serum perfluorinated chemicals and liver enzymes in US adults. Am J Gastroenterol 105:1354\u20131363. https:\/\/doi.org\/10.1038\/ajg.2009.707","journal-title":"Am J Gastroenterol"},{"key":"1865_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2020.106125","volume":"145","author":"K Steenland","year":"2020","unstructured":"Steenland K, Fletcher T, Stein CR et al (2020) Review: evolution of evidence on PFOA and health following the assessments of the C8 science panel. Environ Int 145:106125. https:\/\/doi.org\/10.1016\/j.envint.2020.106125","journal-title":"Environ Int"},{"key":"1865_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1081\/dct-200039773","volume":"27","author":"RG Perkins","year":"2004","unstructured":"Perkins RG, Butenhoff JL, Kennedy GL Jr, Palazzolo MJ (2004) 13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats. Drug Chem Toxicol 27:361\u2013378. https:\/\/doi.org\/10.1081\/dct-200039773","journal-title":"Drug Chem Toxicol"},{"key":"1865_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115922","volume":"9","author":"W Liang","year":"2014","unstructured":"Liang W, Menke AL, Driessen A et al (2014) Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PLoS ONE 9:e115922. https:\/\/doi.org\/10.1371\/journal.pone.0115922","journal-title":"PLoS ONE"},{"key":"1865_CR50","doi-asserted-by":"publisher","first-page":"16789","DOI":"10.1038\/s41598-020-74026-8","volume":"10","author":"A Di Nisio","year":"2020","unstructured":"Di Nisio A, Rocca MS, De Toni L et al (2020) Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA). Sci Rep 10:16789. https:\/\/doi.org\/10.1038\/s41598-020-74026-8","journal-title":"Sci Rep"},{"key":"1865_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010077","author":"D Jahn","year":"2019","unstructured":"Jahn D, Dorbath D, Kircher S et al (2019) Beneficial effects of vitamin D treatment in an obese mouse model of non-alcoholic steatohepatitis. Nutrients. https:\/\/doi.org\/10.3390\/nu11010077","journal-title":"Nutrients"},{"key":"1865_CR52","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00125-022-05695-5","volume":"65","author":"SK Park","year":"2022","unstructured":"Park SK, Wang X, Ding N et al (2022) Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women\u2019s Health Across the Nation (SWAN). Diabetologia 65:1157\u20131168. https:\/\/doi.org\/10.1007\/s00125-022-05695-5","journal-title":"Diabetologia"},{"key":"1865_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116362","volume":"232","author":"K Pan","year":"2023","unstructured":"Pan K, Xu J, Long X, Yang L, Huang Z, Yu J (2023) The relationship between perfluoroalkyl substances and hypertension: a systematic review and meta-analysis. Environ Res 232:116362. https:\/\/doi.org\/10.1016\/j.envres.2023.116362","journal-title":"Environ Res"},{"key":"1865_CR54","doi-asserted-by":"publisher","first-page":"56001","DOI":"10.1289\/ehp11840","volume":"131","author":"B Liu","year":"2023","unstructured":"Liu B, Zhu L, Wang M, Sun Q (2023) Associations between Per-and polyfluoroalkyl substances exposures and blood lipid levels among adults-a meta-analysis. Environ Health Perspect 131:56001. https:\/\/doi.org\/10.1289\/ehp11840","journal-title":"Environ Health Perspect"},{"key":"1865_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2019.104700","volume":"62","author":"AC Behr","year":"2020","unstructured":"Behr AC, Plinsch C, Braeuning A, Buhrke T (2020) Activation of human nuclear receptors by perfluoroalkylated substances (PFAS). Toxicol In Vitro\u202f:Int J Publ Assoc BIBRA 62:104700. https:\/\/doi.org\/10.1016\/j.tiv.2019.104700","journal-title":"Toxicol In Vitro :Int J Publ Assoc BIBRA"},{"key":"1865_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28020479","author":"D Kowalska","year":"2023","unstructured":"Kowalska D, Sosnowska A, Bulawska N et al (2023) How the structure of per-and polyfluoroalkyl substances (PFAS) influences their binding potency to the peroxisome proliferator-activated and thyroid hormone receptors-an in silico screening study. Molecules. https:\/\/doi.org\/10.3390\/molecules28020479","journal-title":"Molecules"},{"key":"1865_CR57","doi-asserted-by":"publisher","DOI":"10.1289\/ehp1062","volume":"125","author":"N Matilla-Santander","year":"2017","unstructured":"Matilla-Santander N, Valvi D, Lopez-Espinosa MJ et al (2017) Exposure to perfluoroalkyl substances and metabolic outcomes in pregnant women: evidence from the spanish inma birth cohorts. Environ Health Perspect 125:117004. https:\/\/doi.org\/10.1289\/ehp1062","journal-title":"Environ Health Perspect"},{"key":"1865_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.151739","volume":"808","author":"M Xu","year":"2022","unstructured":"Xu M, Legradi J, Leonards P (2022) Using comprehensive lipid profiling to study effects of PFHxS during different stages of early zebrafish development. Sci Total Environ 808:151739. https:\/\/doi.org\/10.1016\/j.scitotenv.2021.151739","journal-title":"Sci Total Environ"},{"key":"1865_CR59","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.envpol.2019.01.064","volume":"247","author":"J Bassler","year":"2019","unstructured":"Bassler J, Ducatman A, Elliott M et al (2019) Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. Environ Pollut 247:1055\u20131063. https:\/\/doi.org\/10.1016\/j.envpol.2019.01.064","journal-title":"Environ Pollut"},{"key":"1865_CR60","doi-asserted-by":"publisher","first-page":"115974","DOI":"10.1016\/j.envpol.2020.115974","volume":"272","author":"W Shao","year":"2021","unstructured":"Shao W, Xu J, Xu C et al (2021) Early-life perfluorooctanoic acid exposure induces obesity in male offspring and the intervention role of chlorogenic acid. Environ Pollut 272:115974. https:\/\/doi.org\/10.1016\/j.envpol.2020.115974","journal-title":"Environ Pollut"},{"key":"1865_CR61","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/toxsci\/kfaa148","volume":"178","author":"M Pfohl","year":"2020","unstructured":"Pfohl M, Ingram L, Marques E et al (2020) Perfluorooctanesulfonic acid and perfluorohexanesulfonic acid alter the blood lipidome and the hepatic proteome in a murine model of diet-induced obesity. Toxicol Sci 178:311\u2013324. https:\/\/doi.org\/10.1093\/toxsci\/kfaa148","journal-title":"Toxicol Sci"},{"key":"1865_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/jpet.105.093773","volume":"316","author":"RN Dhir","year":"2006","unstructured":"Dhir RN, Dworakowski W, Thangavel C, Shapiro BH (2006) Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 316:87\u201394. https:\/\/doi.org\/10.1124\/jpet.105.093773","journal-title":"J Pharmacol Exp Ther"},{"key":"1865_CR63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/hep.28514","volume":"64","author":"JS Klair","year":"2016","unstructured":"Klair JS, Yang JD, Abdelmalek MF et al (2016) A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology (Baltimore, MD) 64:85\u201391. https:\/\/doi.org\/10.1002\/hep.28514","journal-title":"Hepatology (Baltimore, MD)"},{"key":"1865_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106843","volume":"157","author":"K Roth","year":"2021","unstructured":"Roth K, Yang Z, Agarwal M et al (2021) Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury. Environ Int 157:106843. https:\/\/doi.org\/10.1016\/j.envint.2021.106843","journal-title":"Environ Int"},{"key":"1865_CR65","doi-asserted-by":"publisher","first-page":"120566","DOI":"10.1016\/j.envpol.2022.120566","volume":"316","author":"T Schillemans","year":"2023","unstructured":"Schillemans T, Iszatt N, Remy S et al (2023) Cross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies. Environ Pollut 316:120566. https:\/\/doi.org\/10.1016\/j.envpol.2022.120566","journal-title":"Environ Pollut"},{"issue":"Suppl 1","key":"1865_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13383","volume":"23","author":"N Stratakis","year":"2022","unstructured":"Stratakis N, Rock S, La Merrill MA et al (2022) Prenatal exposure to persistent organic pollutants and childhood obesity: a systematic review and meta-analysis of human studies. Obes Rev: off J Int Assoc Study Obes 23(Suppl 1):e13383. https:\/\/doi.org\/10.1111\/obr.13383","journal-title":"Obes Rev: off J Int Assoc Study Obes"},{"key":"1865_CR67","doi-asserted-by":"publisher","first-page":"2216943","DOI":"10.1080\/07853890.2023.2216943","volume":"55","author":"W Cheng","year":"2023","unstructured":"Cheng W, Li M, Zhang L et al (2023) Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017\u20132018. Ann Med 55:2216943. https:\/\/doi.org\/10.1080\/07853890.2023.2216943","journal-title":"Ann Med"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-024-01865-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-024-01865-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-024-01865-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T09:23:20Z","timestamp":1725528200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-024-01865-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,19]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1865"],"URL":"https:\/\/doi.org\/10.1007\/s10552-024-01865-5","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,19]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The survey protocol was approved by the Ethics Review Board of the National Center for Health Statistics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants have signed a written informed consent form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants in the NHANES study provided consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}